Top search result for "enjaymo" in Treatments. To see all results and access other features, sign up for free.

Enjaymo (Sutimlimab-jome)

Overview
Enjaymo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2022 to treat cold agglutinin disease (CAD), a type of autoimmune hemolytic anemia (AIHA). Enjaymo is also known by its… read more

myAIHAteam is the social network for those living with Autoimmune Hemolytic Anemia. Get the emotional support you need from others like you, and gain practical advice and insights on managing treatment or therapies for Autoimmune Hemolytic Anemia. myAIHAteam is the only social network where you can make genuine connections and get access to trustworthy information you need, all in one place.

myAIHAteam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment. No information on myAIHAteam should be construed as medical and/or health advice.

Your Privacy is Our Priority

Connect with others who understand.

Top search result for "enjaymo" in Treatments. To see all results and access other features, sign up for free.

Enjaymo (Sutimlimab-jome)